rejection

As nouns the difference between ostracism and rejection

is that ostracism is (historical) in ancient athens (and some other cities), the temporary banishment by popular vote of a citizen considered dangerous to the state while rejection is the act of rejecting.

As nouns the difference between elimination and rejection

is that elimination is elimination while rejection is the act of rejecting.

As nouns the difference between rejection and antirrhesis

is that rejection is the act of rejecting while antirrhesis is (rhetoric) a discrediting or rejection of an authority.

As nouns the difference between rejection and anticonformity

is that rejection is the act of rejecting while anticonformity is a form of individualism that is an active rejection of conformity.

As nouns the difference between rejection and nonrejection

is that rejection is the act of rejecting while nonrejection is lack of rejection; acceptance or validation.

As nouns the difference between rejection and knockback

is that rejection is the act of rejecting while knockback is a blow that causes the recipient to fall or move backwards, a knock back; a recoil.

As nouns the difference between rejection and odulimomab

is that rejection is the act of rejecting while odulimomab is a mouse monoclonal antibody under investigation as a drug to prevent transplant rejection and to treat various immunological diseases.

As nouns the difference between rejection and daclizumab

is that rejection is the act of rejecting while daclizumab is a humanized monoclonal antibody used to prevent rejection in organ transplantation, especially in kidney transplants.

As nouns the difference between rejection and cedelizumab

is that rejection is the act of rejecting while cedelizumab is a monoclonal antibody that acts on the immune system and may have applications in preventing organ transplant rejections and in treating autoimmune diseases.

As nouns the difference between rejection and basiliximab

is that rejection is the act of rejecting while basiliximab is a monoclonal antibody used to prevent rejection in organ transplantation, especially in kidney transplants.